Clinical practice. Initial management of epilepsy.

(62%), the cause is unknown. Stroke (9.0%), head trauma (9.0%), alcohol (6.0%), neurodegenerative disease (4.0%), static encephalopathy (3.5%), brain tumors (3.0%), and infection (2.0%) account for most remaining cases. 4 Although cerebrovascular causes are more common in the elderly, the cause is still unknown in 25 to 40% of patients who are 65 years of age or older. 5

[1]  A. H. Dinsmore,et al.  New England , 1894, Letters from America.

[2]  L. Herzberg.  CARBAMAZEPINE AND BRADYCARDIA , 1978, The Lancet.

[3]  D. Benson,et al.  Depression in epilepsy. Significance and phenomenology. , 1986, Archives of neurology.

[4]  C. Nappi,et al.  Reproductive Endocrine Disorders in Women with Primary Generalized Epilepsy , 1988, Epilepsia.

[5]  T. Pedley.  Current Practice of Clinical Electroenceph‐alography , 1980, Neurology.

[6]  W. Hauser,et al.  Prevalence of Epilepsy in Rochester, Minnesota: 1940–1980 , 1991, Epilepsia.

[7]  C. Nappi,et al.  Interictal depression in epilepsy , 1992, Epilepsy Research.

[8]  A. Pakarinen,et al.  Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy , 1993 .

[9]  G. Mendis,et al.  Plasma activities of hepatic enzymes in patients on anticonvulsant therapy , 1993, Seizure.

[10]  V. Myllylä,et al.  Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. , 1994, The New England journal of medicine.

[11]  W. Hauser,et al.  Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984 , 1993, Epilepsia.

[12]  M. Maly,et al.  Valproate‐mediated disturbances of hemostasis , 1994, Neurology.

[13]  A. Berg,et al.  Relapse following discontinuation of antiepileptic drugs , 1994, Neurology.

[14]  W. Hauser,et al.  Incidence of Acute Symptomatic Seizures in Rochester, Minnesota, 1935‐1984 , 1995, Epilepsia.

[15]  D. Spencer,et al.  Refractory epilepsy: comparison of MR imaging, CT, and histopathologic findings in 117 patients. , 1996, Radiology.

[16]  A. Beydoun.  Monotherapy Trials of New Antiepileptic Drugs , 1997, Epilepsia.

[17]  G. Avanzini,et al.  Antiepileptic Drugs as a Cause of Worsening Seizures , 1998, Epilepsia.

[18]  M. Knip,et al.  Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy , 1998, Annals of neurology.

[19]  J. Annegers,et al.  The Incidence of Epilepsy and Unprovoked Seizures in Multiethnic, Urban Health Maintenance Organizations , 1999, Epilepsia.

[20]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[21]  S. Schachter,et al.  Valproate and the Polycystic Ovarian Syndrome: Final Thoughts , 2001, Epilepsia.

[22]  F. Drislane,et al.  Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy , 2003, Annals of neurology.

[23]  A. Richens,et al.  Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop , 2003, Epilepsy Research.

[24]  T. Betts,et al.  A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy , 2003, Seizure.

[25]  E. Perucca,et al.  Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs , 2003, The Lancet Neurology.

[26]  L. Forsgren,et al.  Incidence and prevalence , 2004 .

[27]  J. Clayton-Smith,et al.  A note on Pierre Marie (1853–1940) , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  Yuan-Tsong Chen,et al.  A marker for Stevens–Johnson syndrome , 2004 .

[29]  R. Sheth.  Metabolic concerns associated with antiepileptic medications , 2004, Neurology.

[30]  B. Bourgeois,et al.  Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy , 2004, Neurology.

[31]  M. Drezner.  Treatment of anticonvulsant drug-induced bone disease , 2004, Epilepsy & Behavior.

[32]  E. Beghi,et al.  Should Antiepileptic Drugs Be Withdrawn in Seizure-Free Patients? , 2004, CNS drugs.

[33]  Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society , 2004 .

[34]  C. Harden.  Polycystic Ovaries and Polycystic Ovary Syndrome in Epilepsy: Evidence for Neurogonadal Disease , 2005, Epilepsy currents.

[35]  R. Marcus,et al.  Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy , 2005, Annals of neurology.

[36]  G. Baker,et al.  Neuropsychological effects of exposure to anticonvulsant medication in utero , 2005, Neurology.

[37]  Y. Sheline,et al.  Depression and Brain Dysfunction , 2005 .

[38]  A. Marson,et al.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial , 2005, The Lancet.

[39]  A. Herzog,et al.  Sexual hormones and epilepsy: threat and opportunities , 2005, Current opinion in neurology.

[40]  K. Haynes,et al.  Use of Antiepileptic Drugs in Patients with Kidney Disease , 2006, Seminars in dialysis.

[41]  Tracy Glauser,et al.  ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes , 2006, Epilepsia.

[42]  K. Meador,et al.  Rapid detection of major depression in epilepsy: a multicentre study , 2006, The Lancet Neurology.

[43]  V. Biton.  Weight Change and Antiepileptic Drugs: Health Issues and Criteria for Appropriate Selection of an Antiepileptic Agent , 2006, The neurologist.

[44]  M. Bialer.  Generic Products of Antiepileptic Drugs (AEDs): Is It an Issue? , 2007, Epilepsia.

[45]  E. Ben-Menachem,et al.  Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures , 2007, Epilepsia.

[46]  S. Duncan.  Teratogenesis of sodium valproate , 2007, Current opinion in neurology.

[47]  H. Mrabet,et al.  Epidemiological and medical aspects of epilepsy in the elderly. , 2007, La Tunisie medicale.

[48]  S Shinnar,et al.  Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society , 2007, Neurology.

[49]  Jing Shen,et al.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial , 2007, The Lancet.

[50]  E. Ben-Menachem.  Weight issues for people with epilepsy—A review , 2007, Epilepsia.

[51]  P. Pennell,et al.  Pharmacology of antiepileptic drugs during pregnancy and lactation , 2007, Epilepsy & Behavior.

[52]  T. Schwartz,et al.  Reassessment: Neuroimaging in the emergency patient presenting with seizure (an evidence-based review) , 2007, Neurology.

[53]  Esben Agerbo,et al.  Epilepsy and risk of suicide: a population-based case–control study , 2007, The Lancet Neurology.

[54]  Michael Westerveld,et al.  Global cognitive function in children with epilepsy: A community‐based study , 2008, Epilepsia.

[55]  A. Beydoun,et al.  Valproate‐induced thrombocytopenia: a prospective monotherapy study , 2008, Epilepsia.

[56]  B. Bourgeois,et al.  Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies , 2008, Epilepsia.

[57]  A. Berg,et al.  Risk of recurrence after a first unprovoked seizure , 2008, Epilepsia.